Cited by 323Chronic Obstructive Pulmonary Disease (COPD) ResearchOral microbiology and periodontitis researchAsthma and respiratory diseases

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease

Open access

Huang, Yvonne J., Sethi, Sanjay, Murphy, Timothy, Nariya, Snehal, Boushey, Homer A., Lynch, Susan V.·2014·Journal of Clinical Microbiology

DOI 10.1128/jcm.00035-14PMC PMC4136157

Open this paper in CoChat — free account Open PDF

Abstract

Specific bacterial species are implicated in the pathogenesis of exacerbations of chronic obstructive pulmonary disease (COPD). However, recent studies of clinically stable COPD patients have demonstrated a greater diversity of airway microbiota, whose role in acute exacerbations is unclear. In this study, temporal changes in the airway microbiome before, at the onset of, and after an acute exacerbation were examined in 60 sputum samples collected from subjects enrolled in a longitudinal study of bacterial infection in COPD. Microbiome composition and predicted functions were examined using 16S rRNA-based culture-independent profiling methods. Shifts in the abundance (≥ 2-fold, P < 0.05) of many taxa at exacerbation and after treatment were observed. Microbiota members that were increased at exacerbation were primarily of the Proteobacteria phylum, including nontypical COPD pathogens. Changes in the bacterial composition after treatment for an exacerbation differed significantly among the therapy regimens clinically prescribed (antibiotics only, oral corticosteroids only, or both). Treatment with antibiotics alone primarily decreased the abundance of Proteobacteria, with the prolonged suppression of some microbiota members being observed. In contrast, treatment with corticosteroids alone led to enrichment for Proteobacteria and members of other phyla. Predicted metagenomes of particular microbiota members involved in these compositional shifts indicated exacerbation-associated loss of functions involved in the synthesis of antimicrobial and anti-inflammatory products, alongside enrichment in functions related to pathogen-elicited inflammation. These trends reversed upon clinical recovery. Further larger studies will be necessary to determine whether specific compositional or functional changes detected in the airway microbiome could be useful indicators of exacerbation development or outcome.

Integrity signals

Registry

Crossref · 10.1128/jcm.00035-14

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

vegan: Community Ecology Package
Oksanen, J., Simpson, G. L., Blanchet, F. G., Kindt, R., Legendre, P., Minchin, P. R., O’Hara, R. B., Sólymos, P., Stevens, M. H. H., Szöcs, E., et al. (2001) · doi:10.32614/cran.package.vegan · Cited by 27,099
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
PAUWELS, R. A., Buist, A. S., CALVERLEY, P. M. A., Jenkins, C. R., & Hurd, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,572
Picante: R tools for integrating phylogenies and ecology
Kembel, S. W., Cowan, P. D., Helmus, M. R., Cornwell, W. K., Morlon, H., Ackerly, D. D., Blomberg, S. P., & Webb, C. O. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq166 · Cited by 6,192
Conservation evaluation and phylogenetic diversity
Faith, D. (1992) · Biological Conservation · doi:10.1016/0006-3207(92)91201-3 · Cited by 5,495

Show all 48 references

Sorted by citations

The Microbiome and the Respiratory Tract
Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., & Huffnagle, G. B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105238 · Cited by 953
The Infant Nasopharyngeal Microbiome Impacts Severity of Lower Respiratory Infection and Risk of Asthma Development
Teo, S. M., Mok, D., Pham, K., Kusel, M., Serralha, M., Troy, N., Holt, B. J., Hales, B. J., Walker, M. L., Hollams, E., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.008 · Cited by 953
From hairballs to hypotheses–biological insights from microbial networks
Röttjers, L., & Faust, K. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy030 · Cited by 742
Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype
Segal, L. N., Clemente, J. C., Tsay, J.-C. J., Koralov, S. B., Keller, B. C., Wu, B. G., Li, Y., Shen, N., Ghedin, E., Morris, A., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.31 · Cited by 685
The role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495
The airway microbiome in patients with severe asthma: Associations with disease features and severity
Huang, Y. J., Nariya, S., Harris, J. M., Lynch, S. V., Choy, D. F., Arron, J. R., & Boushey, H. A. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.044 · Cited by 530
Lung microbiome dynamics in COPD exacerbations
Wang, Z., Bafadhel, M., Haldar, K., Spivak, A., Mayhew, D. N., Miller, B. E., Tal‐Singer, R., Johnston, S. L., Ramsheh, M. Y., Barer, M. R., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01406-2015 · Cited by 469
The microbiome and critical illness
Dickson, R. P. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00427-0 · Cited by 460
Functional effects of the microbiota in chronic respiratory disease
Budden, K. F., Shukla, S. D., Rehman, S. F., Bowerman, K. L., Keely, S., Hugenholtz, P., Armstrong-James, D. P. H., Adcock, I. M., Chotirmall, S. H., Chung, K. F., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30510-1 · Cited by 453
Lung microbiome: new insights into the pathogenesis of respiratory diseases
Li, R., Li, J., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01722-y · Cited by 483
Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations
Ritchie, A. I., & Wedzicha, J. A. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.06.007 · Cited by 403
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
O’Dwyer, D. N., Dickson, R. P., & Moore, B. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600279 · Cited by 362
Acute exacerbation of COPD
Ko, F., Chan, K. P., Hui, D., Goddard, J., Shaw, J., Reid, D., & Yang, I. (2016) · Respirology (Carlton South. Print) · doi:10.1111/resp.12780 · Cited by 327
Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology
Taylor, S. L., Leong, L. E. X., Choo, J. M., Wesselingh, S., Yang, I. A., Upham, J. W., Reynolds, P. N., Hodge, S., James, A. L., Jenkins, C., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.03.044 · Cited by 314
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
Mayhew, D. N., Devos, N., Lambert, C., Brown, J. R., Clarke, S. C., Kim, V. L., Magid-Slav, M., Miller, B. E., Ostridge, K., Patel, R. K., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-210408 · Cited by 296
The role of the local microbial ecosystem in respiratory health and disease
Piters, W. A. A. D. S., Sanders, E. A. M., & Bogaert, D. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0294 · Cited by 300
The microbiome in asthma
Huang, Y. J., & Boushey, H. A. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.011 · Cited by 280
The microbiome in respiratory medicine: current challenges and future perspectives
Faner, R., Sibila, O., Agustí, A., Bernasconi, E., Chalmers, J. D., Huffnagle, G. B., Manichanh, C., Molyneaux, P. L., Paredes, R., Pérez Brocal, V., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02086-2016 · Cited by 247
Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age
Stearns, J. C., Davidson, C. J., McKeon, S., Whelan, F. J., Fontes, M. E., Schryvers, A. B., Bowdish, D. M. E., Kellner, J. D., & Surette, M. G. (2015) · The ISME Journal · doi:10.1038/ismej.2014.250 · Cited by 234
Novel aspects of pathogenesis and regeneration mechanisms in COPD
Aldonytė, R., Bagdonas, E., Raudoniūtė, J., & Bružauskaitė, I. (2015) · International Journal of COPD · doi:10.2147/copd.s82518 · Cited by 229
Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma
Simpson, J. L., Daly, J. N., Baines, K. J., Yang, I. A., Upham, J. W., Reynolds, P. N., Hodge, S. J., James, A. L., Hugenholtz, P., Willner, D. L., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00405-2015 · Cited by 210
The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD
Leung, J. M., Tiew, P. Y., Aogáin, M. M., Budden, K. F., Yong, V. F. L., Thomas, S. S., Pethe, K., Hansbro, P. M., & Chotirmall, S. H. (2017) · Respirology · doi:10.1111/resp.13032 · Cited by 205
A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD
Wilkinson, T. M. A., Aris, E., Bourne, S. C., Clarke, S. C., Peeters, M., Pascal, T. G., Schoonbroodt, S., Tuck, A. C., Kim, V., Ostridge, K., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209023 · Cited by 196
Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis
Parris, B. A., O’Farrell, H. E., Fong, K. M., & Yang, I. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.10.54 · Cited by 196
The dynamics of the pulmonary microbiome during mechanical ventilation in the intensive care unit and the association with occurrence of pneumonia
Zakharkina, T., Martín‐Loeches, I., Matamoros, S., Póvoa, P. M. S. R., Torres, A., Kastelijn, J. B., Hofstra, J. J., de Wever, B., de Jong, M. D., Schultz, M. J., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209158 · Cited by 189
Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease
Raftery, A. L., Tsantikos, E., Harris, N. L., & Hibbs, M. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02144 · Cited by 179
Biofilm Models of Polymicrobial Infection
Gabrilska, R. A., & Rumbaugh, K. P. (2015) · Future Microbiology · doi:10.2217/fmb.15.109 · Cited by 161
Airway host-microbiome interactions in chronic obstructive pulmonary disease
Wang, Z., Maschera, B., Lea, S., Kolsum, U., Michalovich, D., Horn, S. V., Traini, C., Brown, J. R., Hessel, E. M., & Singh, D. (2019) · Respiratory Research · doi:10.1186/s12931-019-1085-z · Cited by 159
Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
Sherrard, L. J., Tunney, M. M., & Elborn, J. S. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61137-5 · Cited by 153
COPD and the microbiome
Mammen, M. J., & Sethi, S. (2016) · Respirology · doi:10.1111/resp.12732 · Cited by 153
Risk factors of chronic obstructive pulmonary disease exacerbations
Hogea, P., Tudorache, E., Fildan, A. P., Firă-Mladinescu, O., Marc, M. S., & Oancea, C. I. (2019) · The Clinical Respiratory Journal · doi:10.1111/crj.13129 · Cited by 160
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study
Wang, Z., Singh, R., Miller, B. E., Tal‐Singer, R., Horn, S. V., Tomsho, L., Mackay, A. J., Allinson, J. P., Webb, A. J., Brookes, A. J., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210741 · Cited by 147
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis
Ramsheh, M. Y., Haldar, K., Esteve‐Codina, A., Purser, L., Richardson, M., Müller–Quernheim, J., Greulich, T., Nowiński, A., Barta, I., Stendardo, M., et al. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00035-5 · Cited by 139
Biomarkers of progression of chronic obstructive pulmonary disease (COPD).
Shaw, J. G., Vaughan, A., Dent, A. G., O’Hare, P. E., Goh, F., Bowman, R., Fong, K. M., & Yang, I. A. (2014) · PubMed Central · doi:10.3978/j.issn.2072-1439.2014.11.33 · Cited by 135
Potential Candidates of Natural Antioxidants From Herbs for Treating Lung Disorders: Focus on Redox Balance and Natural Products
Chang, X., Zhou, S., Yan, Z., Zhang, Q., Liu, J., Wang, Y., Guan, X., Wu, Q., & Liu, R. (2025) · Phytotherapy Research · doi:10.1002/ptr.70008 · Cited by 138
Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection
Håkansson, A., Orihuela, C. J., & Bogaert, D. (2018) · Physiological Reviews · doi:10.1152/physrev.00040.2016 · Cited by 129
The Impact of Immunosenescence on Pulmonary Disease
Murray, M., & Chotirmall, S. H. (2015) · Mediators of Inflammation · doi:10.1155/2015/692546 · Cited by 125
Microbiomes in respiratory health and disease: An Asia‐Pacific perspective
Chotirmall, S. H., Gellatly, S. L., Budden, K. F., Aogáin, M. M., Shukla, S. D., Wood, D., Hugenholtz, P., Pethe, K., & Hansbro, P. M. (2017) · Respirology · doi:10.1111/resp.12971 · Cited by 125
The Microbiome
Hoffmann, A. R., Proctor, L. M., Surette, M. G., & Suchodolski, J. S. (2015) · Veterinary Pathology · doi:10.1177/0300985815595517 · Cited by 121
Mechanistic insight into the function of the microbiome in lung diseases
Ubags, N. D. J., & Marsland, B. J. (2017) · European Respiratory Journal · doi:10.1183/13993003.02467-2016 · Cited by 109
A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs
Scales, B. S., Dickson, R. P., & Huffnagle, G. B. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0316-106r · Cited by 109
The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae
Su, Y.-C., Jalalvand, F., Thegerström, J., & Riesbeck, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02530 · Cited by 114
The sputum microbiome is distinct between COPD and health, independent of smoking history
Haldar, K., George, L., Wang, Z., Mistry, V., Ramsheh, M. Y., Free, R. C., John, C., Reeve, N. F., Miller, B. E., Tal‐Singer, R., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01448-3 · Cited by 108
Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling
Polosukhin, V. V., Richmond, B. W., Du, R., Cates, J., Wu, P., Nian, H., Massion, P. P., Ware, L. B., Lee, J. W., Кононов, А. В., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0759oc · Cited by 106
Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety
Li, K., Chen, Z., Huang, Y. H., Zhang, R., Luan, X.-Q., Lei, T., & Chen, L. (2019) · Respiratory Research · doi:10.1186/s12931-019-1246-0 · Cited by 110
COPD and Gut–Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics
Qu, L., Cheng, Q., Wang, Y., Mu, H., & Zhang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.868086 · Cited by 104
Microbial Communities in the Upper Respiratory Tract of Patients with Asthma and Chronic Obstructive Pulmonary Disease
Park, H., Shin, J. W., Park, S.-G., & Kim, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109710 · Cited by 101
A randomised, placebo-controlled trial of anti–interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease
Calverley, P. M. A., Sethi, S., Dawson, M., Ward, C. K., Finch, D. K., Penney, M., Newbold, P., & van der Merwe, R. (2017) · Respiratory Research · doi:10.1186/s12931-017-0633-7 · Cited by 100
Links between Infections, Lung Cancer, and the Immune System
Budişan, L., Zănoagă, O., Braicu, C., Pîrlog, R., Covaliu, B. F., Eşanu, V., Korban, S. S., & Berindan‐Neagoe, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179394 · Cited by 107
The microbiome and lung cancer
Maddi, A., Sabharwal, A., Violante, T., Manuballa, S., Genco, R. J., Patnaik, S. K., & Yendamuri, S. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.12.88 · Cited by 95
Multi-omic meta-analysis identifies functional signatures of airway microbiome in chronic obstructive pulmonary disease
Wang, Z., Yang, Y., Yan, Z., Liu, H., Chen, B., Liang, Z., Wang, F., Miller, B. E., Tal‐Singer, R., Yi, X., et al. (2020) · The ISME Journal · doi:10.1038/s41396-020-0727-y · Cited by 96
The impact of lung microbiota dysbiosis on inflammation
Yang, D., Xing, Y., Song, X., & Qian, Y. (2019) · Immunology · doi:10.1111/imm.13139 · Cited by 100
Transcriptionally Active Lung Microbiome and Its Association with Bacterial Biomass and Host Inflammatory Status
Ren, L., Zhang, R., Rao, J. Y., Xiao, Y., Zhang, Z., Yang, B., Cao, D., Zhong, H., Ning, P., Shang, Y., et al. (2018) · mSystems · doi:10.1128/msystems.00199-18 · Cited by 90
Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease
Healy, C. M., Muñoz‐Wolf, N., Strydom, J., Faherty, L., Williams, N. C., Kenny, S., Donnelly, S. C., & Cloonan, S. M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01722-y · Cited by 90
How inhaled corticosteroids target inflammation in COPD
Lea, S., Higham, A., Beech, A. S., & Singh, D. (2023) · European Respiratory Review · doi:10.1183/16000617.0084-2023 · Cited by 89
Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures
Gupta, S., Shariff, M., Chaturvedi, G., Sharma, A., Goel, N., Yadav, M., Mortensen, M. S., Sørensen, S. J., Mukerji, M., & Chauhan, N. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-83524-2 · Cited by 82
Ammonia induce lung tissue injury in broilers by activating NLRP3 inflammasome via Escherichia/Shigella
Liu, Q. X., Zhou, Y. Q., Li, X. M., Ma, D. D., Xing, S. J., Feng, J. H., & Zhang, M. H. (2020) · Poultry Science · doi:10.1016/j.psj.2020.03.019 · Cited by 81
Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions
Huang, Y. J., Erb‐Downward, J. R., Dickson, R. P., Curtis, J. L., Huffnagle, G. B., & Han, M. K. (2016) · Translational research · doi:10.1016/j.trsl.2016.06.007 · Cited by 82
The airway microbiome in COPD, bronchiectasis and bronchiectasis‐COPD overlap
Tiew, P. Y., Jaggi, T. K., Chan, L., & Chotirmall, S. H. (2020) · The Clinical Respiratory Journal · doi:10.1111/crj.13294 · Cited by 78
Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial
Brill, S., Law, M. W.-M., El‐Emir, E., Allinson, J. P., James, P. L., Maddox, V., Donaldson, G. C., McHugh, T. D., Cookson, W., Moffatt, M. F., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207194 · Cited by 76
Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis
Moghoofei, M., Jamalkandi, S. A., Moein, M., Salimian, J., & Ahmadi, A. (2019) · Infection · doi:10.1007/s15010-019-01350-1 · Cited by 76
Linking microbiota and respiratory disease
Hauptmann, M., & Schaible, U. E. (2016) · FEBS Letters · doi:10.1002/1873-3468.12421 · Cited by 77
COPD as a Disease of Immunosenescence
Cho, W., Lee, C. G., & Kim, L. K. (2019) · Yonsei Medical Journal · doi:10.3349/ymj.2019.60.5.407 · Cited by 79
Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases
Paudel, K. R., Dharwal, V., Patel, V. K., Galvão, I., Wadhwa, R., Malyla, V., Shen, S., Budden, K. F., Hansbro, N. G., Vaughan, A., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00554 · Cited by 75
The gut microbiome is a significant risk factor for future chronic lung disease
Liu, Y., Teo, S. M., Méric, G., Tang, H. H. F., Zhu, Q., Sanders, J. G., Vázquez‐Baeza, Y., Verspoor, K. M., Vartiainen, V. A., Jousilahti, P., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.12.810 · Cited by 76
Lower airway bacterial microbiome may influence recurrence after resection of early-stage non–small cell lung cancer
Patnaik, S. K., Gomez, E. C., Kannisto, E. D., Punnanitinont, A., Dhillon, S. S., Liu, S., & Yendamuri, S. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.01.104 · Cited by 72
Lung Microbiota: Its Relationship to Respiratory System Diseases and Approaches for Lung-Targeted Probiotic Bacteria Delivery
Yüksel, N., Gelmez, B., & Yıldız-Peköz, A. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00323 · Cited by 75
Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae
Mallia, P., Finney, L., Ritchie, A. I., Pollard, E., & Johnston, S. L. (2014) · International Journal of COPD · doi:10.2147/copd.s54477 · Cited by 71
A Refined View of Airway Microbiome in Chronic Obstructive Pulmonary Disease at Species and Strain-Levels
Wang, Z., Liu, H., Wang, F., Yang, Y., Wang, X., Chen, B., Stämpfli, M. R., Zhou, H., Shu, W., Brightling, C. E., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01758 · Cited by 72
Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung
Mouraux, S., Bernasconi, E., Pattaroni, C., Koutsokera, A., Aubert, J.-D., Claustre, J., Pison, C. M., Royer, P., Magnan, A., Kessler, R., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.022 · Cited by 70
COPD is characterized by increased detection of H aemophilus influenzae, S treptococcus pneumoniae and a deficiency of B acillus species
Simpson, J. L., Baines, K. J., Horvat, J. C., Essilfie, A., Brown, A. C., Tooze, M., McDonald, V. M., Gibson, P. G., & Hansbro, P. M. (2016) · Respirology · doi:10.1111/resp.12734 · Cited by 69
Update on non-typeable Haemophilus influenzae- mediated disease and vaccine development
Jalalvand, F., & Riesbeck, K. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1484286 · Cited by 67
Approach to the diagnosis and management of dysbiosis
Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1330903 · Cited by 79
The lung microbiome: clinical and therapeutic implications
Fabbrizzi, A., Amedei, A., Lavorini, F., Renda, T., & Fontana, G. A. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-019-02208-y · Cited by 68
The Microbiome and Sustainable Healthcare
Dietert, R. R., & Dietert, J. M. (2015) · Healthcare · doi:10.3390/healthcare3010100 · Cited by 71
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
Janson, C., Stratelis, G., Miller‐Larsson, A., Harrison, T. W., & Larsson, K. (2017) · International Journal of COPD · doi:10.2147/copd.s143656 · Cited by 63
Acute exacerbations of COPD: risk factors for failure and relapse
Mantero, M., Rogliani, P., Pasquale, M. D., Polverino, E., Crisafulli, E., Guerrero, M., Gramegna, A., Cazzola, M., & Blasi, F. (2017) · International Journal of COPD · doi:10.2147/copd.s145253 · Cited by 61
Past, Present, and Future Research on the Lung Microbiome in Inflammatory Airway Disease
Caverly, L. J., Huang, Y. J., & Sze, M. A. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.05.011 · Cited by 61
Understanding Persistent Bacterial Lung Infections
Pragman, A. A., Berger, J. P., & Williams, B. J. (2016) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000108 · Cited by 60
The lung microbiome and exacerbations of COPD
Dy, R. V., & Sethi, S. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000268 · Cited by 62
Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease
Wang, L., Hao, K., Yang, T., & Wang, C. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.211452 · Cited by 61
Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD
Su, J., Liu, H., Tan, X.-L., Ji, Y. I., Jiang, Y., Prabhakar, M., Rong, Z., Zhou, H., & Zhang, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130736 · Cited by 62
Documento de consenso sobre el diagnóstico y tratamiento de la infección bronquial crónica en la enfermedad pulmonar obstructiva crónica
de la Rosa, D., López-Campos, J. L., Navarrete, B. A., Rubio, M. C., Moreno, R. C., Rivero, J. L. G., Carro, L. M., Fuster, C. O., Martínez‐García, M. Á., Callejas, F. J., et al. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2020.04.023 · Cited by 56
Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state
Yang, C.-Y., Li, S.-W., Chin, C.-Y., Hsu, C., Lee, C., Yeh, Y., & Wu, K.-A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02788-4 · Cited by 60
A ferret model of COPD-related chronic bronchitis
Raju, S. V., Kim, H., Byzek, S. A., Tang, L. P., Trombley, J. E., Jackson, P. L., Rasmussen, L. W., Wells, J. M., Libby, E. F., Dohm, E. D., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87536 · Cited by 58
The Lung Microbiome: A New Frontier for Lung and Brain Disease
Chen, J., Li, T., Ye, C., Zhong, J., Huang, J., Ke, Y., & Sun, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032170 · Cited by 56
Exploring the microbiome in health and disease
Scotti, E., Boué, S., Sasso, G. L., Zanetti, F., Belcastro, V., Poussin, C., Sierro, N., Battey, J. N. D., Gimalac, A., Ivanov, N. V., et al. (2017) · Toxicology Research and Application · doi:10.1177/2397847317741884 · Cited by 56
The porcine respiratory microbiome: recent insights and future challenges
Pirolo, M., Espinosa‐Gongora, C., Bogaert, D., & Guardabassi, L. (2021) · Animal Microbiome · doi:10.1186/s42523-020-00070-4 · Cited by 54
Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians
Sriram, K. B., Cox, A. J., Clancy, R. L., Slack, M., & Cripps, A. W. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1329274 · Cited by 58
Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study
Pragman, A. A., Knutson, K. A., Gould, T. J., Isaacson, R. E., Reilly, C., & Wendt, C. H. (2019) · Respiratory Research · doi:10.1186/s12931-019-1080-4 · Cited by 58
Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial
Wilkinson, T. M. A., Schembri, S., Brightling, C. E., Bakerly, N. D., Lewis, K. E., MacNee, W., Rombo, L., Hedner, J. A., Allen, M. B., Walker, P. P., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.07.100 · Cited by 56
Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study
Xue, Q., Xie, Y., He, Y., Yu, Y., Fang, G., Yu, W., Wu, J., Li, J., Zhao, L., Deng, X., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-32901-0 · Cited by 53
Heterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposal
López-Campos, J. L., & Agustí, A. G. N. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00242-8 · Cited by 51
Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review
Huber, M. B., Wacker, M. E., Vogelmeier, C. F., & Leidl, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123292 · Cited by 54
The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD): Current perspectives
Dima, E., Kyriakoudi, A., Kaponi, M., Vasileiadis, I., Stamou, P., Koutsoukou, A., Koulouris, N. G., & Rovina, N. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.08.012 · Cited by 53
Sputum microbiome profiling in COPD: beyond singular pathogen detection
Ditz, B., Christenson, S. A., Rossen, J. W. A., Brightling, C. E., Kerstjens, H. A. M., van den Berge, M., & Faiz, A. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214168 · Cited by 55
Oral and nasal probiotic administration for the prevention and alleviation of allergic diseases, asthma and chronic obstructive pulmonary disease
Jamalkandi, S. A., Ahmadi, A., Ahrari, I., Salimian, J., Karimi, M., & Ghanei, M. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000116 · Cited by 51
Role of infection in exacerbations of chronic obstructive pulmonary disease
Miravitlles, M., & Anzueto, A. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000154 · Cited by 49
The Effect of Influenza Virus on the Human Oropharyngeal Microbiome
Ramos‐Sevillano, E., Wade, W. G., Mann, A., Gilbert, A., Lambkin‐Williams, R., Killingley, B., Nguyen‐Van‐Tam, J. S., & Tang, C. M. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy821 · Cited by 48
Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer—A review
Nagasaka, M., Sexton, R. E., Alhasan, R., Rahman, S. B., Azmi, A. S., & Sukari, A. W. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102841 · Cited by 51

Authors: Huang, Y. J., Sethi, S., Murphy, T., Nariya, S., Boushey, H. A., & Lynch, S. V.
Affiliations: University of California, San Francisco (US)
Buffalo VA Medical Center (US)
University at Buffalo, State University of New York (US)
ORCID: Huang, Yvonne J.
Sethi, Sanjay
Murphy, Timothy
Boushey, Homer A.
Lynch, Susan V.
Venue: Journal of Clinical Microbiology
Publisher: American Society for Microbiology
Published: 2014-08
Volume: 52
Issue: 8
Pages: 2813-2823
ISSN: 0095-1137 (ISSN-L)
1098-660X
DOI: 10.1128/jcm.00035-14
PMC: PMC4136157
OpenAlex: W2135623379
Cited by: 323
References: 48
Citations by year: 2026: 11 · 2025: 12 · 2024: 25 · 2023: 25 · 2022: 30 · 2021: 33 · 2020: 35 · 2019: 28 · 2018: 24 · 2017: 38 · 2016: 27 · 2015: 29 · 2014: 6
FWCI: 26.69
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Clinical Microbiology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Heart, Lung, and Blood Institute (K23HL105572, HL105572)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords: chronic obstructive pulmonary disease, COPD exacerbations, airway microbiome, sputum microbiota, Proteobacteria, antibiotic therapy, oral corticosteroids, inflammation
MeSH terms: Aged, Aged, 80 and over, DNA, Bacterial, DNA, Ribosomal, Humans, Longitudinal Studies, Male, Middle Aged, Phylogeny, Respiratory System, RNA, Ribosomal, 16S, Sputum, Cluster Analysis, Sequence Analysis, DNA, Proteobacteria, Pulmonary Disease, Chronic Obstructive, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks